Status:
COMPLETED
Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass
Lead Sponsor:
Clinica Gastrobese
Conditions:
Gastroesophageal Reflux Disease
Morbid Obesity
Eligibility:
All Genders
18-70 years
Brief Summary
The hypothesis of this study was that gastric bypass (GBP) ameliorates gastroesophageal reflux disease (GERD) in morbidly obese patients.
Detailed Description
The investigators studied the impact of this surgical procedure on GERD in patients with morbid obesity. Esophageal syndromes were evaluated according to the Montreal Consensus, where troublesome sym...
Eligibility Criteria
Inclusion
- Morbid obesity
- Acceptance to undergo open gastric bypass
Exclusion
- Prior gastroesophageal surgery
- Achalasia
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00951093
Start Date
March 1 2007
End Date
December 1 2012
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clínica Gastrobese
Passo Fundo, Rio Grande do Sul, Brazil, 99010112